172 related articles for article (PubMed ID: 8262559)
1. Influence of the antigen delivery system on immunoglobulin isotype selection and cytokine production in response to influenza A nucleoprotein.
Brett SJ; Dunlop L; Liew FY; Tite JP
Immunology; 1993 Oct; 80(2):306-12. PubMed ID: 8262559
[TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
3. Selection of the same major T cell determinants of influenza nucleoprotein after vaccination or exposure to infectious virus.
Brett SJ; Gao XM; Liew FY; Tite JP
J Immunol; 1991 Sep; 147(5):1647-52. PubMed ID: 1715366
[TBL] [Abstract][Full Text] [Related]
4. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
5. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery.
Pertmer TM; Roberts TR; Haynes JR
J Virol; 1996 Sep; 70(9):6119-25. PubMed ID: 8709236
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
[TBL] [Abstract][Full Text] [Related]
7. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
8. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
9. Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses.
Tite JP; Russell SM; Dougan G; O'Callaghan D; Jones I; Brownlee G; Liew FY
J Immunol; 1988 Dec; 141(11):3980-7. PubMed ID: 3263440
[TBL] [Abstract][Full Text] [Related]
10. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier.
Tite JP; Gao XM; Hughes-Jenkins CM; Lipscombe M; O'Callaghan D; Dougan G; Liew FY
Immunology; 1990 Aug; 70(4):540-6. PubMed ID: 2168340
[TBL] [Abstract][Full Text] [Related]
11. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ
Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex control of the class of the immune response to the hapten trinitrophenyl.
Dieli F; Asherson GL; Bonanno CT; Sireci G; Salerno A
Immunology; 1995 Mar; 84(3):355-9. PubMed ID: 7751016
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms.
Metzger DW; McNutt RM; Collins JT; Buchanan JM; Van Cleave VH; Dunnick WA
Eur J Immunol; 1997 Aug; 27(8):1958-65. PubMed ID: 9295032
[TBL] [Abstract][Full Text] [Related]
15. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
Bliss J; Van Cleave V; Murray K; Wiencis A; Ketchum M; Maylor R; Haire T; Resmini C; Abbas AK; Wolf SF
J Immunol; 1996 Feb; 156(3):887-94. PubMed ID: 8558014
[TBL] [Abstract][Full Text] [Related]
16. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.
Lasarte JJ; Corrales FJ; Casares N; López-Díaz de Cerio A; Qian C; Xie X; Borrás-Cuesta F; Prieto J
J Immunol; 1999 May; 162(9):5270-7. PubMed ID: 10228002
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
[TBL] [Abstract][Full Text] [Related]
18. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.
Kosiewicz MM; Alard P; Streilein JW
J Immunol; 1998 Nov; 161(10):5382-90. PubMed ID: 9820512
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.
Finkelman FD; Katona IM; Mosmann TR; Coffman RL
J Immunol; 1988 Feb; 140(4):1022-7. PubMed ID: 3125247
[TBL] [Abstract][Full Text] [Related]
20. Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses.
Thomson JA; Troutt AB; Kelso A
Immunology; 1993 Feb; 78(2):185-92. PubMed ID: 8473011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
